NCT02062229

Brief Summary

Infertility is a common problem, affecting perhaps one couple in six, the majority of whom now seek medical care. It is becoming a social challenge because it is responsible for personal and interpersonal discomfort and anxiety. A major obstacle to meaningful study of the epidemiology of male infertility is the difficulty in accurate diagnosis of the presence or absence of a problem. Traditionally, the diagnosis of male infertility is facilitated by the conventional assessment of the semen profile - constructed according to recognized guidelines (i.e. WHO) and including pH, cell count and motility - but no specific biomarkers are available. We sought to determine the oxysterol and fatty acid lipidome with the ai of finding a lipid biomarker useful for the diagnosis of male infertility.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 7, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 13, 2014

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

December 11, 2015

Status Verified

December 1, 2015

Enrollment Period

1.7 years

First QC Date

February 7, 2014

Last Update Submit

December 10, 2015

Conditions

Keywords

oxidative stressoxysterolsfatty acidsseminal fluid

Outcome Measures

Primary Outcomes (1)

  • Oxysterol profiling in seminal fluid

    Oxysterol profiling will be assessed in seminal fluid by state of the art GC/MS

    1 day

Secondary Outcomes (1)

  • Fatty acids lipidomics

    1 day

Other Outcomes (1)

  • Vitamin E concentration in seminal fluid

    1 day

Study Arms (4)

Halthy controls

Subjects not affected by any disease and with normal seminal fluid characteristics

Oligospermia

Infertile subjects with oligospermia

Varicocele

Infertile subjects with varicocele

Asthenospermia

Infertile subjects with asthenospermia

Eligibility Criteria

Age18 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Subjects referring to an infertility center

You may qualify if:

  • clinically healthy subjects and clinical healthy subjects with infertility

You may not qualify if:

  • subjects with endocrine, cardiovascular, metabolic, inflammatory and neurologic diseases or cancer
  • subjects taking medicines and/or supplements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Civic Hospital, Fertility Unit

Latina, 04100, Italy

Location

Related Publications (1)

  • Zerbinati C, Caponecchia L, Rago R, Leoncini E, Bottaccioli AG, Ciacciarelli M, Pacelli A, Salacone P, Sebastianelli A, Pastore A, Palleschi G, Boccia S, Carbone A, Iuliano L. Fatty acids profiling reveals potential candidate markers of semen quality. Andrology. 2016 Nov;4(6):1094-1101. doi: 10.1111/andr.12236. Epub 2016 Sep 27.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Collection of male seminal fluid

MeSH Terms

Conditions

Infertility, Male

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital Diseases

Study Officials

  • Rocco Rago, M.D.

    Civic Hospital

    PRINCIPAL INVESTIGATOR
  • Luigi Iuliano, M.D.

    University of Roma La Sapienza

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

February 7, 2014

First Posted

February 13, 2014

Study Start

February 1, 2012

Primary Completion

October 1, 2013

Study Completion

June 1, 2016

Last Updated

December 11, 2015

Record last verified: 2015-12

Locations